Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,068,832

« Back to Dashboard
Patent 6,068,832 protects DULERA and ASMANEX HFA and is included in two NDAs.

Summary for Patent: 6,068,832

Title: Chlorofluorocarbon-free mometasone furoate aerosol formulations
Abstract:The invention relates to suspension aerosol formulations which exhibit stable particle sizes, containing mometasone furoate, about 1 to about 10 weight percent ethanol and 1,1,1,2,3,3,3-Heptafluoropropane as the propellant. A surfactant, such as oleic acid, can also be included. These formulations are suitable for use in metered dose inhalers.
Inventor(s): Berry; Julianne (Westfield, NJ), Sequeira; Joel A. (Edison, NJ), Chaudry; Imtiaz A. (North Caldwell, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/920,611
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Device; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 11th percentile
Forward Citations: 1st percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Merck Sharp Dohme
formoterol fumarate; mometasone furoate
AEROSOL, METERED;INHALATION022518-001Jun 22, 2010RXYesYes6,068,832► subscribeY TREATMENT OF ASTHMA
Merck Sharp Dohme
formoterol fumarate; mometasone furoate
AEROSOL, METERED;INHALATION022518-002Jun 22, 2010RXYesYes6,068,832► subscribeY TREATMENT OF ASTHMA
Merck Sharp Dohme
mometasone furoate
AEROSOL, METERED;INHALATION205641-001Apr 25, 2014RXYesNo6,068,832► subscribeY TREATMENT OF ASTHMA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.